Real-world and natural history data for drug evaluation in Duchenne muscular dystrophy: suitability of the North Star Ambulatory Assessment for comparisons with external controls
Open Access
- 25 February 2022
- journal article
- research article
- Published by Elsevier in Neuromuscular Disorders
- Vol. 32 (4) , 271-283
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Use of historical control data for assessing treatment effects in clinical trialsPharmaceutical Statistics, 2013
- The cooperative international neuromuscular research group duchenne natural history study—a longitudinal investigation in the era of glucocorticoid therapy: Design of protocol and the methods usedMuscle & Nerve, 2013
- Development of a Functional Assessment Scale for Ambulatory Boys with Duchenne Muscular DystrophyPhysiotherapy Research International, 2011
- Viewpoint: Randomised controlled trials using invasive ‘placebo’ controls are unethical and should be excluded from Cochrane Reviews2011
- An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational StudiesMultivariate Behavioral Research, 2011
- Optimal caliper widths for propensity‐score matching when estimating differences in means and differences in proportions in observational studiesPharmaceutical Statistics, 2011
- Hierarchical Commensurate and Power Prior Models for Adaptive Incorporation of Historical Information in Clinical TrialsBiometrics, 2011
- Reliability of the North Star Ambulatory Assessment in a multicentric settingNeuromuscular Disorders, 2009
- How "blind" are double-blind studies?Journal of Consulting and Clinical Psychology, 1991
- The combination of randomized and historical controls in clinical trialsJournal of Chronic Diseases, 1976